Market Tracker

05/26 5:16pm ET

Halozyme Therapeutics Inc (NASDAQ:HALO)

12.41
Delayed Data
As of May 26
 -0.19 / -1.51%
Today’s Change
7.70
Today|||52-Week Range
15.20
+25.61%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close12.60
Today’s open12.52
Day’s range12.36 - 12.64
Volume671,809
Average volume (3 months)1,292,602
Market cap$1.6B
Dividend yield--
Data as of 3:59pm ET, 05/26/2017

Growth & Valuation

Earnings growth (last year)-224.00%
Earnings growth (this year)-22.52%
Earnings growth (next 5 years)+13.27%
Revenue growth (last year)+8.61%
P/E ratioNM
Price/Sales8.62
Price/Book--

Competitors

 Today’s
change
Today’s
% change
RDUSRadius Health Inc-1.27-3.51%
ONCESpark Therapeutics I...-2.63-4.73%
BPMCBlueprint Medicines ...-1.94-5.06%
AVXSAveXis Inc-1.49-1.94%
Data as of 4:00pm ET, 05/26/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$146.7M
Annual profit (last year)-$103.0M
Net profit margin-70.23%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts